Natsudaidain inhibits tumour necrosis factor-alpha and cyclooxygenase-2 production by suppressing p38 MAPK phosphorylation but not p65 NFkappaB phosphorylation, and that natsudaidain might alleviate inflammatory diseases. This product can be used for research in the fields of medicine and pharmacy.
Molecular Weight
418.39
Molecular Formula
C21H22O9
Form
Powder
Purity
≥98%, determined by HPLC.
Identity
Confirmed by MS and NMR.
Applications
Natsudaidain can be used for research in the fields of medicine and pharmacy.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
